Featuring
perspectives from Prof Francois-Clement Bidard, Dr Erika Hamilton,
Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Hope S Rugo,
including the following topics:
Introduction (0:00)
Role of Genomic Assays in Treatment
Decision-Making for Localized ER-Positive, HER2-Negative Breast
Cancer — Dr Goetz (6:03)
Integration of Ovarian Function Suppression
into the Management of Breast Cancer in Premenopausal Patients
— Dr Burstein (33:34)
Role of CDK4/6 Inhibitors and Other Novel
Agents in Therapy for ER-Positive Localized Breast Cancer — Dr
Hurvitz (52:35)
Optimizing the Use of Neoadjuvant and
Adjuvant Therapy for Triple-Negative Breast Cancer — Dr
O’Shaughnessy (1:16:18)
Emerging Role of Circulating Tumor DNA
Evaluation in the Management of Breast Cancer — Dr Pusztai
(1:42:03)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.